• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LTβR 过表达促进浆细胞积累。

LTβR overexpression promotes plasma cell accumulation.

机构信息

Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, CA, United States of America.

Department of Medicine, University of California, San Francisco, CA, United States of America.

出版信息

PLoS One. 2022 Aug 4;17(8):e0270907. doi: 10.1371/journal.pone.0270907. eCollection 2022.

DOI:10.1371/journal.pone.0270907
PMID:35925983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9352096/
Abstract

Multiple myeloma (MM), a malignancy of plasma cells (PCs), has diverse genetic underpinnings and in rare cases these include amplification of the lymphotoxin b receptor (Ltbr) locus. LTβR has well defined roles in supporting lymphoid tissue development and function through actions in stromal and myeloid cells, but whether it is functional in PCs is unknown. Here we showed that Ltbr mRNA was upregulated in mouse PCs compared to follicular B cells, but deficiency in the receptor did not cause a reduction in PC responses to a T-dependent or T-independent immunogen. However, LTβR overexpression (OE) enhanced PC formation in vitro after LPS or anti-CD40 stimulation. In vivo, LTβR OE led to increased antigen-specific splenic and bone marrow (BM) plasma cells responses. LTβR OE PCs had increased expression of Nfkb2 and of the NF-kB target genes Bcl2 and Mcl1, factors involved in the formation of long-lived BM PCs. Our findings suggest a pathway by which Ltbr gene amplifications may contribute to MM development through increased NF-kB activity and induction of an anti-apoptotic transcriptional program.

摘要

多发性骨髓瘤(MM)是一种浆细胞(PCs)的恶性肿瘤,其具有多种遗传基础,在极少数情况下,这些遗传基础包括淋巴毒素 b 受体(Ltbr)基因座的扩增。LTβR 在支持淋巴组织发育和功能方面具有明确的作用,其通过在基质细胞和髓样细胞中的作用发挥作用,但它在 PCs 中是否具有功能尚不清楚。在这里,我们发现与滤泡 B 细胞相比,Ltbr mRNA 在小鼠 PCs 中上调,但受体缺失不会导致对 T 依赖性或 T 非依赖性免疫原的 PC 反应减少。然而,LTβR 过表达(OE)增强了 LPS 或抗 CD40 刺激后体外 PC 的形成。在体内,LTβR OE 导致抗原特异性脾脏和骨髓(BM)浆细胞反应增加。LTβR OE PCs 表达了更多的 Nfkb2 以及 NF-κB 靶基因 Bcl2 和 Mcl1,这些基因参与了长寿 BM PCs 的形成。我们的研究结果表明,Ltbr 基因扩增可能通过增加 NF-κB 活性和诱导抗凋亡转录程序,从而促进 MM 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/19ccdd05f2c7/pone.0270907.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/d39d2dd9c5e2/pone.0270907.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/742c8f140e7b/pone.0270907.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/a2476a280dcf/pone.0270907.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/bf741f6b7ffe/pone.0270907.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/86b63669b7ae/pone.0270907.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/af0341c322c6/pone.0270907.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/19ccdd05f2c7/pone.0270907.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/d39d2dd9c5e2/pone.0270907.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/742c8f140e7b/pone.0270907.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/a2476a280dcf/pone.0270907.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/bf741f6b7ffe/pone.0270907.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/86b63669b7ae/pone.0270907.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/af0341c322c6/pone.0270907.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8790/9352096/19ccdd05f2c7/pone.0270907.g007.jpg

相似文献

1
LTβR overexpression promotes plasma cell accumulation.LTβR 过表达促进浆细胞积累。
PLoS One. 2022 Aug 4;17(8):e0270907. doi: 10.1371/journal.pone.0270907. eCollection 2022.
2
Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.淋巴毒素-β 受体被淋巴毒素-α(1)β(2)和 LIGHT 的激活以 NFκB 依赖的方式促进肿瘤生长。
Int J Cancer. 2011 Mar 15;128(6):1363-70. doi: 10.1002/ijc.25456.
3
Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.成熟的滤泡树突状细胞网络依赖于抗辐射基质细胞表达淋巴毒素β受体以及B细胞表达淋巴毒素β和肿瘤坏死因子。
J Exp Med. 1999 Jan 4;189(1):159-68. doi: 10.1084/jem.189.1.159.
4
Lymphotoxin β receptor-mediated NFκB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem/progenitor cells.淋巴毒素β受体介导的 NFκB 信号通路促进小鼠脑神经干细胞/祖细胞中的神经胶质谱系分化,抑制神经元谱系分化。
J Neuroinflammation. 2018 Feb 20;15(1):49. doi: 10.1186/s12974-018-1074-z.
5
Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.在肿瘤坏死因子受体 1/淋巴毒素β受体 NF-κB 信号的共同作用下,小鼠主动脉平滑肌细胞分化为淋巴组织生成器样细胞。
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):395-402. doi: 10.1161/ATVBAHA.109.191395. Epub 2010 Feb 5.
6
Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype.微环境细胞中的淋巴毒素-β 受体促进具有皮质/成熟免疫表型的 T 细胞急性淋巴细胞白血病的发展。
Br J Haematol. 2015 Dec;171(5):736-51. doi: 10.1111/bjh.13760. Epub 2015 Oct 12.
7
Growth of Murine Splenic Tissue Is Suppressed by Lymphotoxin β-Receptor Signaling (LTβR) Originating from Splenic and Non-Splenic Tissues.源自脾脏和非脾脏组织的淋巴毒素β受体信号(LTβR)抑制小鼠脾脏组织的生长。
PLoS One. 2016 Dec 9;11(12):e0166901. doi: 10.1371/journal.pone.0166901. eCollection 2016.
8
Activation of lymphotoxin-beta receptor enhances the LPS-induced expression of IL-8 through NF-κB and IRF-1.淋巴毒素-β受体的激活通过核因子κB和干扰素调节因子1增强脂多糖诱导的白细胞介素-8表达。
Immunol Lett. 2015 Jun;165(2):63-9. doi: 10.1016/j.imlet.2015.04.001. Epub 2015 Apr 15.
9
Lymphotoxin β receptor signalling executes -driven gastric inflammation in a T4SS-dependent manner.淋巴毒素β受体信号以 T4SS 依赖的方式执行 -driven 驱动的胃炎症。
Gut. 2017 Aug;66(8):1369-1381. doi: 10.1136/gutjnl-2015-310783. Epub 2016 Apr 13.
10
LTβR expression on hematopoietic cells regulates acute inflammation and influences maturation of myeloid subpopulations.造血细胞上的LTβR表达调节急性炎症并影响髓系亚群的成熟。
Innate Immun. 2014 Jul;20(5):461-70. doi: 10.1177/1753425913497242. Epub 2013 Aug 12.

引用本文的文献

1
Reduction of lymphotoxin beta receptor induces cellular senescence via the MDMX-p53 pathway.淋巴毒素β受体的减少通过MDMX-p53途径诱导细胞衰老。
Cell Death Discov. 2025 Aug 29;11(1):416. doi: 10.1038/s41420-025-02708-1.
2
Novel insights: crosstalk with non-puerperal mastitis and immunity.新见解:与非产褥期乳腺炎的串扰和免疫。
Front Immunol. 2024 Aug 1;15:1431681. doi: 10.3389/fimmu.2024.1431681. eCollection 2024.

本文引用的文献

1
A genome-scale screen for synthetic drivers of T cell proliferation.全基因组筛选 T 细胞增殖的合成驱动因素。
Nature. 2022 Mar;603(7902):728-735. doi: 10.1038/s41586-022-04494-7. Epub 2022 Mar 16.
2
BCL2 and MCL1 inhibitors for hematologic malignancies.BCL2 和 MCL1 抑制剂治疗血液系统恶性肿瘤。
Blood. 2021 Sep 30;138(13):1120-1136. doi: 10.1182/blood.2020006785.
3
LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells.LIGHT(TNFSF14)增强人骨髓间充质干细胞的成骨作用。
PLoS One. 2021 Feb 19;16(2):e0247368. doi: 10.1371/journal.pone.0247368. eCollection 2021.
4
LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.LIGHT/LTβR 信号通路调节造血干/祖细胞和白血病干细胞的自我更新和分化。
Nat Commun. 2021 Feb 16;12(1):1065. doi: 10.1038/s41467-021-21317-x.
5
Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils.中性粒细胞中淋巴毒素β受体的表达可预防代谢激活和结肠炎发病机制。
Mucosal Immunol. 2021 May;14(3):679-690. doi: 10.1038/s41385-021-00378-7. Epub 2021 Feb 10.
6
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression.阻断多发性骨髓瘤生态系统中的恶性循环:阻断骨髓内皮细胞上的JAM-A可恢复血管生成稳态并抑制肿瘤进展。
Haematologica. 2021 Jul 1;106(7):1943-1956. doi: 10.3324/haematol.2019.239913.
7
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.多发性骨髓瘤患者衰弱的结构化评估作为老年癌症患者个体化治疗算法的范例
Haematologica. 2020 May;105(5):1183-1188. doi: 10.3324/haematol.2019.242958. Epub 2020 Apr 2.
8
Immune system and bone microenvironment: rationale for targeted cancer therapies.免疫系统与骨微环境:靶向癌症治疗的理论依据
Oncotarget. 2020 Jan 28;11(4):480-487. doi: 10.18632/oncotarget.27439.
9
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.多发性骨髓瘤中抗 CD38 达雷妥尤单抗耐药的机制。
Cells. 2020 Jan 9;9(1):167. doi: 10.3390/cells9010167.
10
Toward personalized treatment in multiple myeloma based on molecular characteristics.基于分子特征的多发性骨髓瘤个体化治疗。
Blood. 2019 Feb 14;133(7):660-675. doi: 10.1182/blood-2018-09-825331. Epub 2018 Dec 26.